VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
JAZZ
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
JAZZJazz Pharmaceuticals plc
$237.72$14.9B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksJAZZQuarterly Financials

Jazz Pharmaceuticals plc (JAZZ) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Jazz Pharmaceuticals plc (JAZZ) quarterly income statement — complete revenue, gross profit & net income history

JAZZ Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue1.07B1.2B1.13B1.05B897.84M1.09B1.05B1.02B901.98M1.01B972.14M957.32M892.81M972.12M940.65M932.88M813.72M896.73M838.12M751.81M
Revenue Growth %19.05%10.09%6.74%2.14%-0.46%7.53%8.52%6.95%1.03%4.1%3.35%2.62%9.72%8.41%12.23%24.08%33.93%34.74%39.48%33.67%
Cost of Goods Sold024.65M257.76M116.27M104.62M128.71M111.61M109.9M95.49M107.24M102.15M97.54M128.64M167.36M133.66M124.21M115.28M136.15M145.22M119.19M
COGS % of Revenue-2.06%22.89%11.12%11.65%11.83%10.58%10.73%10.59%10.6%10.51%10.19%14.41%17.22%14.21%13.31%14.17%15.18%17.33%15.85%
Gross Profit01.17B868.35M929.44M793.22M959.46M943.36M913.92M806.5M904.69M869.99M859.78M764.17M804.76M806.99M808.67M698.44M760.58M692.89M632.62M
Gross Margin %-97.94%77.11%88.88%88.35%88.17%89.42%89.27%89.41%89.4%89.49%89.81%85.59%82.78%85.79%86.69%85.83%84.82%82.67%84.15%
Gross Profit Growth %-100%22.29%-7.95%1.7%-1.65%6.05%8.43%6.3%5.54%12.42%7.81%6.32%9.41%5.81%16.47%27.83%23.1%23.6%24%18.37%
Operating Expenses732.3M264.08M810.84M1.62B849.11M768.69M683.15M714.48M740.29M782.2M697.6M702.14M638.11M1.07B782.23M723.12M610.89M711.2M664.52M702.21M
OpEx % of Revenue68.51%22.04%72%154.52%94.57%70.64%64.76%69.79%82.07%77.3%71.76%73.34%71.47%109.88%83.16%77.52%75.07%79.31%79.29%93.4%
Selling, General & Admin352.7M406.21M530.65M358.4M514.01M369.29M325.77M338.52M351.71M396.03M308.31M340.84M297.92M383.2M358.48M366.47M308.81M398.46M363.68M429.03M
SG&A % of Revenue33%33.91%47.12%34.27%57.25%33.94%30.88%33.06%38.99%39.14%31.71%35.6%33.37%39.42%38.11%39.28%37.95%44.44%43.39%57.07%
Research & Development134.1M171.41M240.7M189.97M180.65M240.5M199.92M220.73M222.85M216.61M234.4M209.24M189.41M172.56M148.87M139.05M129.98M155.44M141.04M132.7M
R&D % of Revenue12.55%14.31%21.37%18.17%20.12%22.1%18.95%21.56%24.71%21.41%24.11%21.86%21.21%17.75%15.83%14.91%15.97%17.33%16.83%17.65%
Other Operating Expenses1000K-1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K
Operating Income336.6M909.2M57.51M-686.39M-55.89M190.77M260.21M199.44M66.21M122.5M172.39M157.64M126.06M-263.39M24.76M85.55M87.55M49.38M28.37M-69.59M
Operating Margin %31.49%75.9%5.11%-65.64%-6.23%17.53%24.67%19.48%7.34%12.11%17.73%16.47%14.12%-27.09%2.63%9.17%10.76%5.51%3.38%-9.26%
Operating Income Growth %702.23%376.59%-77.9%-444.15%-184.42%55.73%50.94%26.52%-47.48%146.51%596.17%84.27%43.98%-633.39%-12.71%222.93%-46%-71.52%-85.54%-135.12%
EBITDA336.6M934.07M235.75M-512.38M108.98M359.19M425.44M362.48M229.59M281.7M334.95M317.21M283.42M-118.66M173.59M241.75M267.26M214M195.95M77.72M
EBITDA Margin %31.49%77.97%20.94%-49%12.14%33.01%40.33%35.4%25.45%27.84%34.45%33.14%31.74%-12.21%18.45%25.91%32.84%23.86%23.38%10.34%
EBITDA Growth %208.86%160.05%-44.59%-241.36%-52.53%27.51%27.02%14.27%-18.99%337.41%92.96%31.22%6.04%-155.45%-11.41%211.03%13.68%-12.68%-26.8%-70.76%
D&A (Non-Cash Add-back)024.87M178.25M174.01M164.87M168.42M165.23M163.03M163.38M159.2M162.56M159.58M157.36M144.73M148.83M156.2M179.71M164.62M167.58M147.31M
EBIT0253.69M57.61M-688.19M-26.01M228.56M260.21M199.44M105.15M234.55M172.39M157.64M187.51M266.71M148.1M160.99M161.09M352.83M28.37M-69.59M
Net Interest Income0-45.41M-48.58M-47.36M-53.71M-51.26M-58.7M-62.02M-66.12M-70.32M-71.5M-73.47M-74.15M-74.13M-80.24M-63.19M-70.68M-88.6M-93.37M-69.42M
Interest Income00000000000000000000
Interest Expense-39.9M45.41M48.58M47.36M53.71M51.26M58.7M62.02M66.12M70.32M71.5M73.47M74.15M74.13M80.24M63.19M70.68M88.6M93.37M69.42M
Other Income/Expense-37.4M-700.91M-48.47M-49.16M-54.46M-57.57M-59.69M-61.53M-69.16M-61.43M-72.75M-77.52M-71.96M-77.38M-87.44M-66.99M-85.37M-97.2M-99.26M-65.11M
Pretax Income299.2M208.28M9.04M-735.55M-110.35M133.2M200.52M137.91M-2.95M61.06M99.64M80.11M54.1M-340.77M-62.67M18.55M2.18M-47.82M-70.89M-134.69M
Pretax Margin %27.99%17.39%0.8%-70.34%-12.29%12.24%19.01%13.47%-0.33%6.03%10.25%8.37%6.06%-35.05%-6.66%1.99%0.27%-5.33%-8.46%-17.92%
Income Tax6.1M4.88M-242.42M-17.08M-17.81M-57.91M-14.53M-30.65M11.67M-33.09M-47.18M-24.32M-15.32M-100.04M-43.03M-16.11M536K-12.47M-18.06M228.62M
Effective Tax Rate %2.04%2.34%-2683.17%2.32%16.14%-43.48%-7.25%-22.23%-395.69%-54.19%-47.34%-30.36%-28.33%29.36%68.65%-86.84%24.55%26.07%25.47%-169.73%
Net Income293.1M203.45M251.41M-718.47M-92.54M191.12M215.06M168.57M-14.62M94.15M146.82M104.44M69.42M-239.95M-19.65M34.66M1.65M-35.35M-52.83M-363.32M
Net Margin %27.42%16.98%22.33%-68.71%-10.31%17.56%20.39%16.46%-1.62%9.3%15.1%10.91%7.78%-24.68%-2.09%3.72%0.2%-3.94%-6.3%-48.33%
Net Income Growth %416.72%6.45%16.91%-526.22%-533.06%102.98%46.48%61.4%-121.06%139.24%847.25%201.28%4114.94%-578.77%62.81%109.54%-98.65%-126.5%-135.64%-416.47%
Net Income (Continuing)293.1M203.4M251.46M-718.47M-92.54M191.12M215.06M168.57M-14.62M94.15M146.82M104.44M69.42M-240.72M-19.65M34.66M1.65M-35.35M-52.83M-363.32M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)4.433.344.08-11.74-1.523.113.422.49-0.231.422.141.521.04-3.81-0.310.550.03-0.57-0.86-6.11
EPS Growth %391.45%7.4%19.3%-571.49%-560.87%119.01%59.81%63.82%-122.12%137.27%790.32%176.36%3869.47%-568.42%63.95%109%-98.75%-124.46%-132.58%-396.6%
EPS (Basic)4.733.284.14-11.74-1.523.163.502.68-0.231.502.331.631.09-3.81-0.310.560.03-0.57-0.86-6.11
Diluted Shares Outstanding66.1M60.98M61.61M61.19M60.98M61.5M63.17M69.63M62.54M69.67M71.29M73.54M73.77M63.05M62.78M63.43M62.91M61.5M61.28M59.45M
Basic Shares Outstanding61.9M60.98M60.7M61.19M60.98M60.54M61.41M62.88M62.54M62.58M63.11M63.99M63.49M63.05M62.78M62.44M61.87M61.5M61.28M59.45M
Dividend Payout Ratio--------------------